These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2251642)

  • 1. Management of non-insulin-dependent diabetes.
    Ward JB
    S Afr Med J; 1990 Dec; 78 Suppl():12-3. PubMed ID: 2251642
    [No Abstract]   [Full Text] [Related]  

  • 2. [The treatment characteristics of non-insulin-dependent diabetes mellitus].
    Balabolkin MI; Kreminskaia VM
    Ter Arkh; 1996; 68(10):5-11. PubMed ID: 9026945
    [No Abstract]   [Full Text] [Related]  

  • 3. Some thoughts on the treatment of non-insulin-dependent diabetes mellitus.
    Somers G; Keymeulen B; Segers O
    Acta Clin Belg; 1993; 48(4):221-7. PubMed ID: 8212973
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of diabetes.
    Tripathy BB; Samal KC
    J Assoc Physicians India; 1983 Apr; 31(4):235-40. PubMed ID: 6358183
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sulfonylurea compounds or biguanides in the treatment of type 2 diabetes?].
    Mehnert H
    Dtsch Med Wochenschr; 1989 Jul; 114(27):1086-8. PubMed ID: 2500320
    [No Abstract]   [Full Text] [Related]  

  • 6. Treating type 2 diabetes: targeting the many causative factors.
    Sutherland JE; Hoehns JD
    J Fam Pract; 2004 May; 53(5):376-88. PubMed ID: 15125823
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral hypoglycemic agents in type II diabetes mellitus.
    Lubbos H; Miller JL; Rose LI
    Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of peroral blood glucose reducing therapy on insulin receptor interactions in patients with type II diabetes mellitus].
    Balabolkin MI; Nedosugova LV; Gavriliuk LM; Gincherman LE
    Ter Arkh; 1983; 55(9):136-40. PubMed ID: 6356436
    [No Abstract]   [Full Text] [Related]  

  • 9. [Secondary sulfonylurea failure].
    Ratzmann KP
    Dtsch Med Wochenschr; 1991 May; 116(21):835-6. PubMed ID: 2032537
    [No Abstract]   [Full Text] [Related]  

  • 10. [Circadian profiles of lactic and pyruvic acid in diabetic patients treated with biguanides and sulfonylureas].
    Cheli V; Buzzo P; Melga P; Accoto S; Prando R
    Clin Ter; 1986 Aug; 118(4):269-75. PubMed ID: 3757467
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of diabetes mellitus].
    Baranov VG; Orkodashvili LSh
    Klin Med (Mosk); 1973 Jul; 51(7):129-36. PubMed ID: 4786254
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral hypoglycaemic agents and insulin therapy.
    Clarke BF
    Br J Clin Pract; 1976; 30(6-8):136-40. PubMed ID: 952708
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prospective studies on the prevention of manifestations of protodiabetes using sulfonylurea compounds and biguanides].
    Adolph W; Panzram G; Ruttmann B
    Z Gesamte Inn Med; 1976 Jan; 31(1):1-6. PubMed ID: 969760
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacologic treatment of diabetes].
    De Montigny P; Clerc C; Descarpentries C
    Perspect Infirm; 2006; 4(2):30-4. PubMed ID: 17184094
    [No Abstract]   [Full Text] [Related]  

  • 15. [Guidelines of the Swiss Diabetic Association concerning oral antidiabetic agents].
    Pernet A; Bäbler M; Ganz K
    Schweiz Rundsch Med Prax; 1986 May; 75(21):626-8. PubMed ID: 3726361
    [No Abstract]   [Full Text] [Related]  

  • 16. [Possibilities and limits of oral diabetes therapy].
    Bruneder H
    Wien Med Wochenschr; 1985 Apr; 135(6-7):147-51. PubMed ID: 3890376
    [No Abstract]   [Full Text] [Related]  

  • 17. [Simplified combination treatment of diabetes mellitus with sulfonylurea compounds and biguanides].
    Bock E
    Z Allgemeinmed; 1975 Jan; 51(1):37. PubMed ID: 1216880
    [No Abstract]   [Full Text] [Related]  

  • 18. [Oral therapy of type II diabetes].
    Haupt E; Schöffling K
    Med Klin (Munich); 1989 Apr; 84(4):203-7. PubMed ID: 2657363
    [No Abstract]   [Full Text] [Related]  

  • 19. [Possible primary prevention of NIDDM (type 2 diabetes) by pharmacological interventions].
    Kawazu S
    Nihon Rinsho; 1997 Oct; 55 Suppl():354-61. PubMed ID: 9392131
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diabetes mellitus and obesity: monotherapy using biguanides].
    Bäbler M
    Schweiz Med Wochenschr; 1973 Apr; 103(17):641-5. PubMed ID: 4704806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.